Daily Roundup

Accent Group Ltd is navigating a challenging retail environment, reporting a 1.9% decline in total sales for the first 19 weeks of FY27, with like-for-like sales falling 3.9%. The company has been hit by a perfect storm of elevated fuel prices, rising interest rates, and weakening consumer confidence. Wholesale sales have been particularly hard hit, dropping 5.1%, while owned retail sales slipped 1.5%. Despite these headwinds, management has implemented key initiatives from its 2030 Strategic Growth Plan that are delivering benefits—though those gains have been offset by the broader sales weakness. As the year heads into its critical trading period with Black Friday, Christmas, and back-to-school on the horizon, the company will be hoping for a turnaround.

**

Smart Parking Ltd is telling a very different story. The company delivered record revenue of $126.0 million in FY26, up 1.2%, while adjusted EBITDA surged 37% to $30.8 million—a much healthier picture. The UK regulatory environment has also turned in the company's favor with a new Private Parking Code of Practice providing a positive tailwind. Looking ahead to FY27, Smart Parking expects a $5 million EBITDA benefit in the UK, with Germany expected to reach break-even during the year. The company is confident about hitting its FY27 targets and has made a strategic move by relocating its CEO to the US to drive long-term growth ambitions.

**

On the medical technology front, Artrya Limited has secured a significant five-year commercial agreement with HonorHealth, a major Arizona health system serving approximately five million people. The deal, valued at a minimum of US$0.5 million over five years, marks Artrya's fifth U.S. customer and importantly, its first inbound customer landed outside its foundation customers and SAPPHIRE study participants. This signals that the company's Salix® AI-powered cloud platform is gaining genuine market traction and opening new customer acquisition channels in the U.S.

**

Imricor Medical Systems has hit several important milestones. The company kicked off its U.S. commercial launch with Rady Children's Hospital-San Diego as its first customer, establishing the country's first commercial interventional MR cardiac catheterization program. Children's Medical Center Dallas quickly followed as the second U.S. customer. On the regulatory front, the FDA has cleared pediatric label expansions for both NorthStar and Vision-MR Diagnostic Catheter, while the manufacturing module for the Vision-MR Ablation Catheter PMA application has been accepted. Strategic partnerships are also bearing fruit—Philips has declared compatibility with Imricor's iMR equipment, opening up the Philips installed base. Financially, Q3 revenue reached US$188,000, a remarkable 437% jump from the prior year period, though the company posted a net loss of $2.9 million for the quarter. Total assets stood at $69.3 million as of September 30, with $62.1 million in cash and equivalents, giving the company a solid runway to execute its U.S. commercial strategy.

**

Finally, Ooh!Media Ltd has cleared another hurdle in its acquisition by BidCo, receiving approval from the Foreign Investment Review Board. With shareholder approval already in hand, the scheme still needs court approval and satisfaction of other conditions before it can close.